Literature DB >> 1714740

Possible involvement of c-myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats.

Y Fujimoto1, Y Ishizaka, T Tahira, H Sone, H Takahashi, K Enomoto, M Mori, T Sugimura, M Nagao.   

Abstract

LEC (Long-Evans with a cinnamon-like coat color) rats develop hepatocellular carcinomas (HCCs) spontaneously. We examined mutations of codons 12, 13, and 61 of the Ha-ras, Ki-ras, and N-ras genes in four HCCs by the polymerase chain reaction (PCR)-single-stranded DNA direct sequencing method. No ras gene mutations were observed, suggesting that ras activation is not involved in spontaneous hepatocarcinogenesis in LEC rats. The expression of mRNAs for c-myc, Ha-ras, c-raf, and the protein phosphatase 2A alpha gene (PP-2A alpha) was also examined in the four HCCs by northern blot analysis. Three of the four HCCs had c-myc expression levels approximately 30-fold higher than that in the liver of control Long-Evans rats with an agouti coat color (LEA), a sibling line of LEC rats, while the remaining HCC had an expression level sevenfold higher than that of control. In contrast, the expression levels of the Ha-ras, c-raf, and PP-2A alpha genes were the same as those in the livers of control rats. Studies of c-myc expression and mitotic index in five other HCCs, two hyperplastic nodules, and two nontumorous portions of livers of HCC-bearing LEC rats that had chronic-phase hepatitis suggested that the high level of c-myc gene expression was not due only to increased cell proliferation but might possibly be more integrally involved in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714740     DOI: 10.1002/mc.2940040405

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  6 in total

1.  The LEC rat: a model for human hepatitis, liver cancer, and much more.

Authors:  M Mori; A Hattori; M Sawaki; N Tsuzuki; N Sawada; M Oyamada; N Sugawara; K Enomoto
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

2.  MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection.

Authors:  Zhihe Liu; Siyun Li; Wei Guo; Yinping Wang; Ming Wang; Ou Bai
Journal:  Biomed Res Int       Date:  2017-10-25       Impact factor: 3.411

Review 3.  Multiple genetic alterations in human carcinogenesis.

Authors:  T Sugimura; M Terada; J Yokota; S Hirohashi; K Wakabayashi
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

4.  Hepatocellular carcinoma induction in LEC rats by a low dose of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  H Sone; K Wakabayashi; H Kushida; K Enomoto; M Mori; N Takeichi; H Tsuda; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1996-01

5.  p53 gene mutation in hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates.

Authors:  Y Fujimoto; L L Hampton; E G Snyderwine; M Nagao; T Sugimura; R H Adamson; S S Thorgeirsson
Journal:  Jpn J Cancer Res       Date:  1994-05

6.  Absence of ras family point mutations at codons 12, 13 and 61 in N-ethyl-N-hydroxyethylnitrosamine- or N-nitrosomorpholine-induced renal cell tumors in rats.

Authors:  K Matsumoto; H Tsuda; T Iwase; M Ito; Y Nishida; F Oyama; K Titani; T Ushijima; M Nagao; I Hirono
Journal:  Jpn J Cancer Res       Date:  1992-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.